Drawing for LUMARA MEDICAL

USPTO serial 99800420

LUMARA MEDICAL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
FAIRBANKS, RONALD L
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with LUMARA MEDICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard L. Hill

Richard L. Hill Dentons Durham Jones Pinegar1557 W. Innovation Way, STE 400Lehi, UT 84043United States

Goods and services

ClassDescriptionStatusFirst use
041Providing continuing medical education courses; Continuing education services, namely, providing live and on-line continuing professional education seminars in the field of medicine; Educational services, namely, conducting classes, seminars, conferences, and workshops in the field of hormone therapy, biomarkers, longevity medicine, and patient-centered care; Arranging and conducting of seminars and workshops in the field of clinical medicine; Educational services, namely, developing curriculum for others in the field of clinical medicine; Organising and conducting of seminars in the field of medicine; Educational services, namely, developing, arranging, and conducting educational conferences and programs and providing courses of instruction in the field of medicine; Educational services, namely, providing online instruction in the field of clinical medicine via an online website; Educational services, namely, providing continuing professional education courses in the field of longevity medicine and patient-centered careACTIVE—
042Software as a service (SAAS) services featuring software for use in database management in the field of clinical education and professional training; Providing a website featuring on-line non-downloadable software that enables users to access training, education, testing, and certification materials in the field of clinical medicine; Providing information about medical and scientific research; Providing scientific information in the field of clinical medicine and longevity; Technical consultancy in relation to research services relating to foods and dietary supplementsACTIVE—
044Providing health care information by telephone, global computer networks, and electronic means; Providing a web site featuring medical information; Providing a website via a global computer network featuring information in the fields of health, cancer treatment, cancer recovery and survival; Providing a website featuring information in the field of the diagnosis and treatment of hormonal disorders and age-related conditions; Medical consultations provided via phone, online chat or videoconferencing; Provision of medical services by health care professionals via the internet or telecommunication networks; Provision of health care and medical services by health care professionals via the Internet or telecommunication networks; Consulting services in the field of healthACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 10, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 10, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 8, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 7, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 7, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 7, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 7, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 7, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 7, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 4, 2026DOCKASSIGNED TO EXAMINER—
Jul 31, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 1, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
May 1, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance